Skip to main content
logo
Amicogen, Inc. (KOSDAQ:092040)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,040.00
-40.00 (-1.30%)
Oct 31, 2025, 3:30 PM KST

Revenue by Product

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202008 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
Raw Pharmaceutical Products
122.31B
Log In
Log In
Log In
Log In
Upgrade
Raw Pharmaceutical Products Growth
1.74%
Log In
Log In
Log In
Log In
Upgrade
Special Enzymes, Bio-new Materials, Bio-medical Materials, Health and Beauty
54.72B
Log In
Log In
Log In
Log In
Upgrade
Special Enzymes, Bio-new Materials, Bio-medical Materials, Health and Beauty Growth
-0.83%
Log In
Log In
Log In
Log In
Upgrade
Consolidated Adjustment
-3.43B
Log In
Log In
Log In
Log In
Upgrade
Consolidated Adjustment Growth
-77.86%
Log In
Log In
Log In
Log In
Upgrade
Treatment of Incurable and Rare Diseases
-
Log In
Log In
Log In
Log In
Upgrade
Treatment of Incurable and Rare Diseases Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202008 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
Overseas
146.97B
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
10.61%
Log In
Log In
Log In
Log In
Upgrade
South Korea
26.64B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-1.48%
Log In
Log In
Log In
Log In
Upgrade